Skip to content

RLAY

Relay Therapeutics, Inc.

Stock

$18.96+0.47 (+2.54%)Close Oct 2, 2026

Net income, 2025
−$276M

Net income

Net income by fiscal year

PeriodNet incomeYoY
2025−$276M—
2024−$338M—
2023−$342M—
2022−$291M—
2021−$364M—
2020−$52M—
2019−$75M—